The most popular data are vital signs, which include such things as blood pressure, heart rate, respiration rate, temperature, oxygen saturation and so forth. Often these data are fed into the EHR ...

With more than 1 million American dying from sepsis annually, providers follow a set of protocols to mitigate a patient’s risk of sepsis. JAMA delves into the updated guidelines, titled Surviving ...

Sepsis, an overwhelming infection, remains among hospitals’ most difficult conditions to identify and treat. Algorithms within electronic medical records have been developed to help clinicians. So how ...

The Sepsis “Sniffer” Algorithm, a digital sepsis alert embedded in an EHR, is a useful tool but it may not be a viable alternative to the Nurse Screening Tool, a manual sepsis alert, according to a ...

Sepsis is a deadly reaction to infection, one that can cause runaway inflammation and a cascade of organ damage. It is estimated to kill at least 350,000 Americans per year. Early detection of this ...

Doctors in Liverpool working with researchers at the Center for Trials Research at Cardiff University have identified promising evidence for the effectiveness of an early and rapid diagnostic test for ...

“Sepsis is more deadly than heart attack and stroke combined — in fact it’s the deadliest, costliest, and arguably most complex condition facing hospitals today.” IntelliSep was cleared by the FDA in ...

A new study explores how artificial intelligence models can support clinical decision-making for sepsis management. Their research, titled “Responsible AI for Sepsis Prediction: Bridging the Gap ...

Qualitative findings from providers and patients for planning implementation of screening clinical breast examination in Soweto, South Africa. This is an ASCO Meeting Abstract from the 2025 ASCO ...

Doctors in Liverpool working with researchers at the Centre for Trials Research, at Cardiff University have identified ...

Prolonged infusion of beta-lactam antibiotics for sepsis or septic shock tended to improve mortality compared with conventional intermittent infusion in the BLING III trial, and a meta-analysis ...